Skip to content

A Pharmacovigilance Study of Brain Oedema

A Pharmacovigilance Study of Brain Oedema in the Food and Drug Administration Adverse Event Reporting System Using Data Mining Algorithms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04311359
Enrollment
9524
Registered
2020-03-17
Start date
2019-05-20
Completion date
2019-11-22
Last updated
2020-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Edema, Brain Edema Caused by Drugs

Brief summary

Literature reports the development of brain oedema following the use of certain drugs. Therefore, this study aims to present a comprehensive disproportionality analysis of brain oedema cases reported to the Food and Drug Administration Adverse Event Reporting System (FAERS).

Detailed description

Brain oedema is a serious neurological condition, as it possesses a significant impact on the functional abilities of an individual by causing irreversible brain damage and potentiates the risk of mortality. Apart from a number of medical conditions causing brain oedema, evidence suggests the association of various drugs with brain oedema. Therefore, this study aims to provide a comprehensive disproportionality analysis of the drug-induced brain oedema reports in the FAERS database.

Interventions

All drugs having 19 or more Brain Oedema cases reported to the FAERS database

Sponsors

University of Peshawar
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Brain Oedema cases reported in the FAERS database till 31/03/2019 * Adverse event reported was included using the MedDRA term: Brain Oedema

Exclusion criteria

* Drugs with less than 19 brain oedema reports

Design outcomes

Primary

MeasureTime frameDescription
Identification of drugs associated with Brain OedemaCases reported to the FAERS database since inception till 31/03/2019The search includes MedDRA (v-22) Preferred Term, Brain Oedema (MedDRA code: 10048962) for the identification of all Brain Oedema case reports and drugs.
Detection of signals of Brain OedemaCases reported to the FAERS database since inception till 31/03/2019Signal detection using disproportionality analysis

Secondary

MeasureTime frame
Trends of Brain Oedema reports in FAERS databaseCases reported to the FAERS database since inception till 31/03/2019
Stratification of new signals with respect to ageCases reported to the FAERS database since inception till 31/03/2019
Description of the population of patients having Brain OedemaCases reported to the FAERS database since inception till 31/03/2019
Trends of Brain Oedema reports in Google searchesCases reported to the FAERS database since inception till 31/03/2019
Stratification of new signals with respect to genderCases reported to the FAERS database since inception till 31/03/2019

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026